Current Value
$14.931 Year Return
Current Value
$14.931 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NVS | 46.97% | $229.68B | +9.71% | 3.29% |
| GSK | 46.64% | $77.41B | -0.98% | 4.17% |
| AZN | 46.52% | $222.49B | -8.17% | 2.17% |
| HLN | 44.24% | $44.47B | +12.76% | 1.80% |
| CB | 43.06% | $112.28B | +7.69% | 1.33% |
| NGG | 42.43% | $69.72B | +16.95% | 4.34% |
| VICI | 42.17% | $35.51B | +10.93% | 5.15% |
| KHC | 41.90% | $32.90B | -13.91% | 5.77% |
| CCEP | 41.00% | $44.00B | +30.83% | 2.30% |
| WTRG | 40.72% | $10.61B | -4.25% | 3.45% |
| MDLZ | 40.61% | $87.58B | +5.11% | 2.79% |
| ING | 40.55% | $68.93B | +26.20% | 5.23% |
| MFA | 40.42% | $954.67M | -18.78% | 15.16% |
| CUBE | 40.17% | $9.61B | -11.13% | 4.91% |
| WPC | 40.05% | $13.90B | +9.07% | 5.57% |
| GMRE | 40.01% | $477.51M | -25.31% | 10.88% |
| BUD | 39.58% | $118.88B | +12.68% | 1.68% |
| SBAC | 39.48% | $24.97B | +10.50% | 1.81% |
| VOD | 39.47% | $26.56B | +20.71% | 4.50% |
| GLPI | 39.24% | $13.21B | -2.34% | 6.36% |
SeekingAlpha
Astria: Betting On Navenibart In The Crowded HAE Arena
Yahoo
Wahei Takeda, known as the "Warren Buffet of Japan" has given probably the least stressful advice about personal finance you've read in a while.
Yahoo
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3% and the actively tr
Yahoo
Of the patients across the two Phase III studies, more than 95% enrolled in the ongoing long-term extension (LTE) study.
Yahoo
Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that targets orexin proteins.
Yahoo
OSAKA, Japan & CAMBRIDGE, Mass., July 14, 2025--Takeda (TSE:4502/NYSE:TAK) today announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of oveporexton (TAK-861), a potential first-in-class investigational oral orexin receptor 2 (OX2R)-selective agonist, in narcolepsy type 1 (NT1). NT1 is caused by the loss of orexin-producing neurons in the brain. Orexin agonists are designed to address this underlying orexin deficiency. Fo
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBO | 0.16% | $228.22M | 0.77% |
| TBLL | 0.26% | $2.12B | 0.08% |
| TPMN | 0.38% | $30.86M | 0.65% |
| ETHW | -0.81% | $318.60M | 0% |
| ETHE | 0.91% | $3.21B | 2.5% |
| QETH | -0.94% | $25.67M | 0.25% |
| CETH | -1.02% | $25.75M | 0% |
| EZET | -1.04% | $44.92M | 0% |
| USFR | 1.04% | $18.61B | 0.15% |
| ETHV | -1.12% | $139.23M | 0% |
| ETHA | -1.13% | $5.64B | 0.25% |
| ETH | -1.16% | $1.40B | 0% |
| FETH | -1.24% | $1.55B | 0.25% |
| IBDQ | 1.32% | $2.96B | 0.1% |
| CANE | -1.39% | $11.17M | 0.29% |
| DBC | 1.57% | $1.26B | 0.87% |
| BLCN | 1.83% | $48.84M | 0.68% |
| AIRR | 1.92% | $4.29B | 0.7% |
| PSQA | 1.95% | $36.50M | 0.2% |
| COMT | 2.00% | $612.23M | 0.48% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| EFAV | 64.99% | $5.48B | 0.2% |
| DWX | 58.90% | $475.48M | 0.45% |
| SCHY | 57.20% | $1.20B | 0.08% |
| IDLV | 56.04% | $401.72M | 0.25% |
| HDEF | 55.45% | $2.05B | 0.09% |
| RWX | 54.33% | $402.17M | 0.59% |
| RODM | 54.15% | $1.16B | 0.29% |
| IGRO | 53.93% | $1.17B | 0.15% |
| QEFA | 53.86% | $917.51M | 0.3% |
| JPIN | 53.83% | $346.30M | 0.37% |
| EFV | 53.49% | $26.33B | 0.33% |
| DTH | 52.99% | $445.48M | 0.58% |
| ACWV | 52.37% | $3.28B | 0.2% |
| DWM | 52.14% | $572.68M | 0.48% |
| KXI | 52.11% | $852.13M | 0.41% |
| VYMI | 51.86% | $11.15B | 0.17% |
| PPH | 51.51% | $544.00M | 0.36% |
| EWL | 51.47% | $1.34B | 0.5% |
| VIGI | 51.41% | $8.39B | 0.1% |
| EWU | 51.13% | $3.06B | 0.5% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| WOLF | <0.01% | $222.55M | -94.14% | 0.00% |
| RLGT | 0.01% | $285.22M | +1.85% | 0.00% |
| SMR | 0.01% | $5.62B | +166.41% | 0.00% |
| PRPL | -0.02% | $75.82M | -41.62% | 0.00% |
| CLSK | 0.02% | $3.54B | -31.15% | 0.00% |
| ANIP | 0.03% | $1.41B | +3.12% | 0.00% |
| CW | 0.04% | $18.36B | +76.58% | 0.18% |
| TEN | 0.04% | $586.58M | -26.80% | 7.74% |
| UEC | -0.04% | $3.05B | +0.88% | 0.00% |
| CLFD | -0.05% | $574.82M | +3.51% | 0.00% |
| TEAM | -0.05% | $50.44B | +6.48% | 0.00% |
| PUBM | 0.06% | $622.20M | -39.47% | 0.00% |
| LFMD | -0.06% | $514.47M | +69.21% | 0.00% |
| VSCO | 0.07% | $1.51B | +4.99% | 0.00% |
| LBRT | -0.09% | $1.99B | -43.21% | 2.56% |
| EPAM | 0.11% | $9.52B | -15.83% | 0.00% |
| DDOG | 0.11% | $47.93B | +7.25% | 0.00% |
| SHEN | -0.12% | $833.28M | -17.54% | 0.66% |
| IBKR | -0.14% | $25.98B | +91.24% | 1.82% |
| CAL | -0.14% | $482.62M | -56.28% | 1.94% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| USDU | -33.44% | $129.88M | 0.5% |
| UUP | -32.94% | $183.22M | 0.77% |
| VIXY | -16.74% | $200.94M | 0.85% |
| VIXM | -10.29% | $22.99M | 0.85% |
| TAIL | -10.23% | $94.90M | 0.59% |
| CTA | -9.69% | $1.07B | 0.76% |
| SGOV | -9.67% | $50.94B | 0.09% |
| KCCA | -9.38% | $109.01M | 0.87% |
| UNG | -8.50% | $416.42M | 1.06% |
| CLIP | -8.26% | $1.51B | 0.07% |
| BIL | -5.68% | $41.78B | 0.1356% |
| DEFI | -4.89% | $15.41M | 0.94% |
| AGZD | -4.64% | $98.57M | 0.23% |
| DBE | -4.46% | $53.74M | 0.77% |
| YBTC | -4.41% | $239.20M | 0.96% |
| BITO | -4.31% | $2.71B | 0.95% |
| KRBN | -4.30% | $160.58M | 0.85% |
| CONY | -4.27% | $1.46B | 1.22% |
| BITB | -4.18% | $4.62B | 0.2% |
| EZBC | -4.15% | $594.58M | 0.29% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HNRG | -18.92% | $664.41M | +77.09% | 0.00% |
| MVO | -14.16% | $69.92M | -35.18% | 21.79% |
| HUSA | -13.71% | $20.46M | -9.15% | 0.00% |
| VSA | -13.10% | $12.16M | +21.20% | 0.00% |
| CMP | -12.96% | $917.73M | +92.91% | 0.00% |
| GRPN | -12.60% | $1.35B | +103.24% | 0.00% |
| CEG | -12.44% | $102.17B | +53.13% | 0.46% |
| DFDV | -12.00% | $361.15M | +2,667.20% | 0.00% |
| JBI | -11.96% | $1.25B | -33.38% | 0.00% |
| STNG | -11.16% | $2.33B | -40.74% | 3.56% |
| HY | -11.01% | $742.91M | -40.69% | 3.35% |
| RDNT | -10.57% | $4.25B | -9.73% | 0.00% |
| CVM | -10.32% | $19.32M | -90.76% | 0.00% |
| TGI | -10.25% | $2.01B | +55.65% | 0.00% |
| AAON | -10.17% | $6.06B | -18.24% | 0.48% |
| STRL | -10.00% | $7.34B | +86.67% | 0.00% |
| PRM | -9.94% | $2.47B | +105.67% | 0.00% |
| LVO | -9.86% | $74.29M | -45.56% | 0.00% |
| GLDD | -9.46% | $749.23M | +23.93% | 0.00% |
| CLS | -9.12% | $18.66B | +164.97% | 0.00% |
